Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$6.81 - $9.71 $204,981 - $292,271
-30,100 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$7.45 - $12.32 $126,650 - $209,440
17,000 Added 129.77%
30,100 $262,000
Q4 2020

Feb 12, 2021

SELL
$10.34 - $13.77 $190,256 - $253,368
-18,400 Reduced 58.41%
13,100 $142,000
Q3 2020

Nov 12, 2020

BUY
$11.73 - $16.25 $215,832 - $299,000
18,400 Added 140.46%
31,500 $376,000
Q2 2020

Aug 12, 2020

SELL
$13.68 - $20.46 $714,096 - $1.07 Million
-52,200 Reduced 79.94%
13,100 $210,000
Q1 2020

May 13, 2020

BUY
$14.83 - $26.72 $968,399 - $1.74 Million
65,300 New
65,300 $1.01 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.